Audrey J. Brooks, PhD University of Arizona CA-AZ node.

Slides:



Advertisements
Similar presentations
Gender Differences in Health Status Among Opiate Users in a 25-Year Follow-up Study Christine Grella & Luz Rodriguez UCLA Integrated Substance Abuse Programs.
Advertisements

M ETHAMPHETAMINE USE IS ASSOCIATED WITH HIV SEXUAL RISK AMONG PATRONS OF ALCOHOL SERVING VENUES IN C APE T OWN Christina S. Meade, PhD Department of Psychiatry.
Aftercare Attendance Partially Moderated by History of Physical Abuse and Gender Louise F. Haynes 1 ; Amy E. Herrin 1 ; Rickey E. Carter 1 ; Sudie E. Back.
Predictors of Change in HIV Risk Factors for Adolescents Admitted to Substance Abuse Treatment Passetti, L. L., Garner, B. R., Funk, R., Godley, S. H.,
The effect of gender specific HIV prevention interventions on heterosexual anal sex among men and women in substance abuse treatment Donald A. Calsyn,
Background: The low retention rates among African Americans in substance abuse treatment (Milligan et al., 2004) combined with the limited number of treatments.
Substance Use: Substance use comparisons included lifetime and past 30 day use (Figure 3) and lifetime use. For past 30 day use, more men reported heroin.
Delay from Testing HIV Positive until First HIV Care for Drug Users: Adverse Consequences and Possible Solutions Barbara J Turner MD, MSEd* John Fleishman.
Correlates of polydrug use among injection drug users: The role of socioeconomic stress and quality of life Marrero CA, Robles RR, Reyes JC, Matos TD,
Behavioral Intention and Partner Type on Condom Use Among Men in Drug Treatment Yong S. Song, PhD, University of California, San Francisco Donald Calsyn,
HIV Risk Behaviors and Alcohol Intoxication among Injection Drug Users in Puerto Rico Tomás D. Matos, MS Center for Addiction Studies Universidad Central.
C. Andres Bedoya, PhD Behavioral Medicine Service Department of Psychiatry Massachusetts General Hospital / Harvard Medical School Factors related to high-risk.
Sexual Risk Behaviors of Self- identified and Behaviorally Bisexual HIV+ Men. By: Matt G. Mutchler, PhD; Miguel Chion, MD, MPH; Nancy Wongvipat, MPH; Lee.
Motivational Interviewing to Improve Treatment Engagement and Outcome* The effect of one session on retention Research findings from the NIDA Clinical.
The Internet: An Emerging Venue for Syphilis Epidemics Among Men Who Have Sex with Men in Los Angeles LAC - DHS Getahun Aynalem, MD, MPH, Kellie Hawkins,
Kathy Burlew, PhD (Chair) Carmen Rosa, MS Audrey Brooks, PhD Jerren Weekes, MA Alyssa Forcehimes, PhD S UBSTANCE U SE T REATMENT WITH E THNIC M INORITIES.
Race/Ethnicity as a Moderator of HIV/STD Sexual Risk Reduction Groups for Women in Substance Abuse Treatment E. Bell 1, S. Tross 2, A.N.C. Campbell 1,3,
Introduction There is a growing body of literature supporting the 12- step approach for stimulant users (see Donovan & Wells 1 for a review). Important.
1 Predictors of Retention in Care Among HIV+ and At-Risk Youth Sion Kim Harris, PhD Cathryn L. Samples, MD, MPH Peter Keenan, RN, C-PNP Durrell J. Fox,
Using Research/Evaluation Questions to Define Data Collection and Findings: Findings from the FY 2004 KTOS Follow-up Study Robert Walker, Allison Mateyoke-Scrivener,
Frequency and type of adverse events associated with treating women with trauma in community substance abuse treatment programs T. KIlleen 1, C. Brown.
Cannabis use and its socio- demographic correlates among in-school adolescents in Zambia Emmanuel Rudatsikira, MD, DrPH Dean & Professor School of Health.
NIDA Grants: U10DA015831, K24DA022288, U10DA020024, K23DA022297, U10DA Predictors of Outcome in the Multi-Site CTN Prescription Opioid Addiction.
Richard Rawson, Ph.D. Valerie Pearce, M.P.H. Rachel Gonzales, Ph.D. Julie Brummer, B.A. UCLA Integrated Substance Abuse Programs May 8, 2007 Treatment.
FUTURE HIV RESEARCH EFFORTS PLANNED FOR THE CLINICAL TRIALS NETWORK James L. Sorensen, Ph.D. Susan Tross, Ph.D. Raul Mandler, M.D. University of California,
High Prevalence of Sexual Minority Status in a Sample of Women at High Risk for HIV Infection: Associated Individual-level Factors and Sexual Risk Behaviors.
EVENT LEVEL: Sex obtained through aggression will frequently be unprotected GLOBAL LEVEL: Men who have perpetrated sexual aggression will be more likely.
Effect of Depression on Smoking Cessation Outcomes Sonne SC 1, Nunes EV 2, Jiang H 2, Gan W 2, Tyson C 1, Reid MS 3 1 Medical University of South Carolina,
Obtaining housing associated with achieving abstinence after detoxification in adults with addiction Tae Woo Park, Christine Maynié-François, Richard Saitz.
Specific Aims  Modify a previously used ACASI (audio computer assisted structured interview) assessment tool, the Sexual Behavior Inventory (SBI), for.
CARIBBEAN BASIN AND HISPANIC ADDICTION TECHNOLOGY TRANSFER CENTER Effects of a Two-facet Intervention to Reduce HIV Risk Behaviors Among Hispanic Drug.
Increased exposure to an HIV risk reduction protocol associated with a reduction in drug abuse severity Louise F. Haynes 1 ; Rickey E. Carter 1 ; Amy E.
CCTN September 6 th, Recent Scientific Publications from the Clinical Trials Network David Liu, M.D. (CTN-0029) Harold Perl, Ph.D. (CTN-0015) Paul.
Relationship Power & Sexual Risk in a Sample of Drug-Involved Women Aimee Campbell, MSSW Columbia University School of Social Work Social Intervention.
Participants were recruited from 6 drug free, psychosocial treatment (PT) and 5 methadone maintenance (MM) programs (N = 628) participating in a NIDA Clinical.
Crack Cocaine, HIV, and African American Women Alison Hamilton, Ph.D. UCLA Department of Psychiatry Integrated Substance Abuse Programs.
Abstinence Incentives for Methadone Maintained Stimulant Users: Outcomes for Those Testing Stimulant Positive vs Negative at Study Intake Maxine L. Stitzer.
Patient and Staff Satisfaction in Outpatient Substance Abuse Treatment Programs A. Kulaga 1, B. McClure 1, J. Rotrosen 1, P. Crits-Christoph 2, S. Ring-Kurtz.
Reducing Sex under the Influence for Substance Abuse Treatment Patients Symposium Presentation at the American Psychological Association Annual Convention,
Introduction Introduction Alcohol Abuse Characteristics Results and Conclusions Results and Conclusions Analyses comparing primary substance of abuse indicated.
Introduction Results and Conclusions Categorical group comparisons revealed no differences on demographic or social variables. At admission to treatment,
Abstinence Incentive Effects in Psychosocial Counseling Patients Testing Stimulant Positive vs Negative at Treatment Entry Maxine L. Stitzer Johns Hopkins.
Table 1. Prediction model for maximum daily dose of buprenorphine-naloxone in a 12-week treatment condition Baseline Predictors Maximum Daily Dose Standardized.
Introduction Results and Conclusions Analyses of demographic and social variables revealed that women were more likely to have children, be living in a.
Predicting Pregnancy Risk among Women Attending an STD Clinic Judith Shlay MD, MSPH Denver Public Health September 21, 2008 CityMatCH Conference.
Relational Discord at Conclusion of Treatment Predicts Future Substance Use for Partnered Patients Wayne H. Denton, MD, PhD; Paul A. Nakonezny, PhD; Bryon.
D. Hien 1, T. KIlleen 2, A. Campbell 1, H. Jiang 1, E. Nunes 1, 1 Columbia University, New York, NY, USA. 2 Medical University of South Carolina, Charleston,
METHADONE VS. NON-METHADONE PATIENTS IN A THERAPEUTIC COMMUNITY: TEST OF EQUIVALENCY James L. Sorensen 1,2, S. Andrews 1,2, K. L. Delucchi 1,3, B. Greenberg.
Predicting Sexual Risk Taking and Dysfunction in Women: Relevance of Sexual Inhibition and Sexual Excitation Cynthia A. Graham, Ph.D., 1,2,6 Stephanie.
Texas COSIG Project Gender Differences in Substance Use Severity and Psychopathology in Clients with Co-Occurring Disorders 5 th Annual COSIG Grantee Meeting.
Combined Pharmacological and Behavioral Therapy and HIV Risk Reduction Jennifer Schroeder, David Epstein, Katherine Belendiuk, Jessica Willner-Reid, John.
Vivia V. McCutcheon, Howard J. Edenburg, John R. Kramer, Kathleen K. Bucholz 9 th Annual Guze Symposium St. Louis, MO February 19, 2009 Gender Differences.
Baseline Characteristics by Primary Substance of Abuse of Outpatient Clients in a Web-based Intervention Trial Aimee N. C. Campbell, Ph.D. 1,2,3, Edward.
Sex under the Influence is Common for Substance Abuse Treatment Patients Donald Calsyn, Ph.D. 1,2, Mary Hatch-Maillette, Ph.D. 1, Suzanne Doyle, Ph.D.
Ten Years of Pharmacotherapy Trials in the CTN: An Overview.
Predictors of study retention in addiction treatment trials KORTE JE 1, MAGRUDER KM 1,2, KILLEEN TK 1, SONNE SC 1, SAMPSON RR 1 and BRADY KT 1,2 1. Medical.
Introduction Results and Conclusions Numerous demographic variables were found to be associated with treatment completion. Completers were more likely.
Howard Newville 1, James L. Sorensen 1, Donald A. Calsyn 2 1 University of California, San Francisco, San Francisco, CA 2 University of Washington, Seattle,
Housing Status and HIV Risk Behaviors Among Homeless and Housed Persons with HIV in the United States The findings and conclusions in this presentation.
Randomized Controlled CTN Trial of OROS-MPH + CBT in Adolescents with ADHD and Substance Use Disorders Paula Riggs, M.D., Theresa Winhusen, PhD., Jeff.
Background  Substance abusers are at risk for HIV and other STIs.  Anal intercourse (AI) is riskier than vaginal intercourse.  Studies of AI have focused.
Results from the STEAM Survey Elizabeth Barash, MPH.
Measuring Sexual Compulsivity Among Young Adults Kimberly R. McBride, Ph.D. 1,2 & Michael Reece, Ph.D., MPH 2,3 1 Department of Pediatrics, Section of.
Medication Adherence and Substance Abuse Predict 18-Month Recidivism among Mental Health Jail Diversion Program Clients Elizabeth N. Burris 1, Evan M.
Trends in Access to Substance Abuse Treatment for Women and Men: Jeanne C. Marsh, PhD, Hee-Choon Shin, PhD, Dingcai Cao, PhD University of Chicago.
PURPOSE BACKGROUND RESULTS STUDY DESIGN & METHODS HIV Risk Behaviors Among Male Prisoners Participating in a Randomized Clinical Trial of Methadone Maintenance.
Associations Between Recent Gender- Based Violence and Pregnancy, Sexually Transmitted Infections, Condom Use Practices, and Negotiation of Sexual Practices.
Predictors of study retention in drug abuse treatment trials
Hatch-Maillette, M. 1, Calsyn, D. A1,2, Doyle, S. 1, Woods, A
The Relationship between Recent Alcohol Use and Sexual Behaviors/STDs: Gender Differences among STD Clinic Patients Heidi E. Hutton PhD, Mary E. McCaul.
Presentation transcript:

Audrey J. Brooks, PhD University of Arizona CA-AZ node

Gender SIG Collaborators Christina S. Meade, Ph.D., NNE node Jennifer Sharpe Potter, Ph.D., M.P.H., NNE node Yuliya Lokhnygina, Ph.D., DCRI Donald A. Calsyn, Ph.D., PNW node Shelly Greenfield, M.D., M.P.H., NNE node Paul Wakim, PhD, NIDA representative

Background Rising rates of HIV in women highlight the need to identify unique factors associated with risk behaviors in women to help inform risk reduction interventions. Evidence of gender differences in frequency of HIV risk behaviors. Multiple risk factors associated with HIV risk behaviors have been identified in the literature. Few studies have examined whether risk factors vary by gender.

Purpose To examine gender differences in the rates and correlates of HIV sexual and drug risk behaviors in a sample of clients participating in 5 multi-site trials of the NIDA Clinical Trials Network. To test whether multiple risk factors for HIV risk behaviors differ by gender. Does gender moderate the impact of stimulant use, alcohol and drug severity, psychiatric severity, abuse history, family/social relationships, legal status and housing stability?

Methods Secondary data analysis of baseline CAB data from CTN-0001/ CTN Buprenorphine/Naloxone versus Clonidine for Inpatient/ Outpatient Opiate Detoxification (Ling et al., 2005) CTN-0005 – Motivational Interviewing to Improve Treatment Engagement and Outcome in Outpatient Substance Users (Carroll et al., 2006) CTN-0006 / CTN Motivational Incentives for Enhanced Recovery in Stimulant Users in Drug Free Methadone Maintenance Clinics (Petry et al., 2005; Pierce et al., 2006)

Measures HIV Risk Behavior Scale (HRBS) Sex and Drug Risk Behaviors Composites Individual sex and drug risk items ASI-Lite Composites Alcohol, Drug, and Psychiatric Symptom Severity, Family/Social Relationships, Legal Problems ASI-Lite derived variables Demographics Housing Stability (length at address) Stimulant use: stimulant only, stimulants + opioids, opioids only, other drug use Lifetime abuse: physical only, sexual only, both physical + sexual

Statistical Analysis Gender differences in sociodemographic characteristics and HIV risk behaviors Chi-square tests for categorical variables and Wilcoxon two-sample tests for continuous variables Gender differences in risk factors associated with HIV risk behaviors Ordinal logistic regression analysis using partial proportional odds model were conducted to identify variables associated with HIV sex risk composite Linear regression models were conducted to identify variables associated with HIV drug risk composite Models adjusted for age, gender, education, ethnicity, living arrangements Gender interaction tested first The ASI composite results are described using a clinically meaningful difference unit (0.1) as the measurement unit

Participant Characteristics CharacteristicMale N=790 (55%) Female N=790 (45%) Total N=1429 Age37.6 ± ± ±9.7 Education12.2 ± ± ±2.0 Ethnicity* White371 (47.0%)325 (50.9%)696 (48.7%) African-American276 (34.9%)251 (39.3%)527 (36.9%) Hispanic68 (8.6%)13 (2.0%)81 (5.6%) Other75 (9.5%)50 (7.8%)125 (8.8%) Living with Partner306 (38.7%)244 (38.2%)550 (38.5%) *p<.0001

Participant Characteristics CharacteristicMale N=790 (55%) Female N=790 (45%) Total N=1429 Employment** Full-time431 (54.6%)270 (42.3%)701 (49.1%) Part-time122 (15.4%)110 (17.2%)232 (16.2%) Other237 (30.0%)259 (40.5%)496 (34.7%) Primary Drug* Heroin/Opiates144 (18.2%)99 (15.5%)243 (17.0%) Stimulants144 (18.2%)161 (25.2%)305 (21.3%) Stimulants/Opiates315 (39.9%)247 (38.6%)562 (39.4%) Other drug187 (23.7%)132 (20.7%)319(22.3%) *p<.0001; +p<.01

HIV Sex Risk Behaviors Past 30-days *p<.008 N=790 N=639 N=504 N=388

Unprotected Sex *p<.016 * * N=484 N=357N=83 N=31 N=39 N=41 N=82 N=31

HIV Drug Risk Behaviors Past 30-days *p<.0008 * * N=790 N=639 N=250 N=151 N=221 N=129 N=227 N=132

HIV Risk Composites *p<.043 * * N=208 N=124 N=488 N=379

Sex Risk Behavior Gender Effects Variable High risk: OR (95% CI) High or moderate risk: OR (95% CI)χ 2 (df)p-value Alcohol use composite women1.11 ( )7.77 (1)0.005 men0.98 ( )0.32 (1)0.57 Psychiatric composite women 1.14 ( ) (1) men0.96 ( ) 0.84 (1)0.36 Family/social composite women 1.03 ( )1.01 ( ) 0.23 (1)0.89 men 0.80 ( )1.01 ( ) 11.1 (2)0.004

Drug Risk Behavior Gender Effects VariableLinear regression coefficient (SD) tp-value Alcohol use composite women0.56 (0.28) men-0.24 (0.21)

Main Effects Sex Risk Behaviors Stimulant use Drug use severity Sexual abuse history only Sexual and physical abuse history Legal problems Drug Risk Behaviors Drug use severity Sexual abuse history negatively related

Summary of Findings Women engaged in higher risk sexual behavior overall, were more likely to have multiple partners, and have unprotected sex with regular partners. Alcohol and psychiatric severity were associated with engaging in higher risk sexual behaviors for women. Alcohol use severity associated with engaging in higher risk drug behaviors for women. Men with impaired family/social relationships were less likely to engage in high risk sexual behavior. Men more likely to inject drugs. Confirmed relationship between stimulant use, drug severity, abuse history, and legal severity and risk behaviors in treatment-seeking sample.

Conclusions Findings consistent with other studies reporting higher rates of high risk sexual behavior for women. Studies incorporating gender into the analyses have found similar relationships between gender and HIV risk factors. Underscores the importance of examining the role of gender in studies of HIV risk behavior. Comprehensive assessment of HIV risk behaviors needs to occur at treatment entry. In addition to targeting women and men separately, the content of the intervention may need to reflect the unique risk factors.